AB

AbbVie

- NYSE:ABBV
Last Updated 2022-05-24

Indeed Snapshot

Track AbbVie reviews on Indeed to uncover insights on employee sentiment
Ticker Symbol Entity Name As Of Date Profile Url Name Website Industry Description Revenue Headquarters location CEO Rating: CEO (%) Rating: CEO Responses Count Rating: Overall Happiness: Compensation score Happiness: Support score Happiness: Purpose score Happiness: Flexibility score Happiness: Energy score Happiness: Work Happiness score Happiness: Trust score Happiness: Learning score Happiness: Belonging score Happiness: Inclusion score Happiness: Overall score Happiness: Appreciation score Happiness: Achievement score Happiness: Responses Count Review Count Ratings Responses Count Rating: Culture & Values Rating: Compensation & Benefits Rating: Job Security & Advancement Rating: Senior Management Rating: Worklife Balance Interview: Duration Responses count Interview Duration Interview: Difficulty Responses count Interview Difficulty Interview: Experience Responses count Interview Experience Work Culture: Stressful (0) to Relaxed (1) Ratio Work Culture: Slow Paced (0) to Fast Paced (1) Ratio Work Culture: Competitive (0) to Collaborative (1) Ratio Date Added Date Updated Sector Industry
nyse:abbv https://www.indeed.com/cmp/pharmacyclics,-an-abbvie-company May 23rd, 2022 12:00AM Open Pharmacyclics, an AbbVie Company Pharmaceutical & Biotechnology Pharmacyclics is an AbbVie company based in Silicon Valley, California and focused on developing and commercializing small-molecule medicines for the treatment of cancers and immune-mediated diseases for which there is great unmet medical need. We seek to discover innovative therapies to improve standards of care and strive to help our patients rediscover the Magic of Normal. Pharmacyclics is committed to the development and commercialization of novel therapies intended to improve the quality and duration of life and to resolve serious unmet medical needs for cancer patients. Pharmacyclics is a wholly-owned subsidiary of AbbVie (NYSE:ABBV), a global, research-based biopharmaceutical company. Oncology is a key therapeutic area for AbbVie, with a portfolio consisting of three marketed products and a pipeline containing multiple promising new molecules that are being studied in more than 200 clinical trials for over 20 different types of cancer. More than 1,200 Pharmacyclics and AbbVie research scientists, clinicians, marketing, operations, and corporate professionals work in the San Francisco Bay Area. They combine their expertise in immuno-oncology, stem cells, and cell-signaling with their knowledge of bispecific antibodies, antibody-drug conjugates (ADCs), and covalent-inhibitor technologies to discover and develop novel cancer treatments. Together, we are striving to outsmart cancer. RRv1_100M_500M 3.00 41.00 41.00 2.70 3.40 2.70 2.50 2.90 11.00 About two weeks 11.00 MEDIUM 11.00 FAVORABLE May 23rd, 2022 05:14AM May 23rd, 2022 05:14AM Health Care Pharmaceuticals & Biotechnology
nyse:abbv https://www.indeed.com/cmp/forest-pharmaceuticals May 23rd, 2022 12:00AM Open Forest Pharmaceuticals 3.80 138.00 138.00 3.40 3.70 3.10 3.30 3.50 May 23rd, 2022 05:14AM May 23rd, 2022 05:14AM Health Care Pharmaceuticals & Biotechnology
nyse:abbv https://www.indeed.com/cmp/abbvie May 23rd, 2022 12:00AM Open AbbVie Pharmaceutical & Biotechnology AbbVie’s mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people’s lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women’s health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on Twitter, Facebook, Instagram, YouTube and LinkedIn. RRv1_OVER_10B Richard A. Gonzalez 3.90 73.0 68.0 73.0 69.0 66.0 64.0 64.0 71.0 62.0 66.0 64.0 70.0 72.0 399.0 1195 1200 3.70 4.00 3.40 3.40 3.70 260.00 About a week 292.00 MEDIUM 301.00 FAVORABLE May 23rd, 2022 05:14AM May 23rd, 2022 05:14AM Health Care Pharmaceuticals & Biotechnology
nyse:abbv https://www.indeed.com/cmp/zeltiq-aesthetics May 23rd, 2022 12:00AM Open Zeltiq Aesthetics Zeltiq Aesthetics Inc. (NASDAQ: ZLTQ) is a global medical equipment supplier. The company's products include the CoolSculpting System which is used to do lipolysis, and Cryolipolysis as well as non-invasive technologies for plastic surgery. Cryolipolysis is an owned trademark of the company and it refers to equipment to destroy fat cells. The company has clearance from the U.S. Food and Drug Administration. RRv1_100M_500M 3.80 16.00 16.00 3.60 4.20 3.20 3.40 3.70 5.00 MEDIUM 5.00 FAVORABLE May 23rd, 2022 05:14AM May 23rd, 2022 05:14AM Health Care Pharmaceuticals & Biotechnology
nyse:abbv https://www.indeed.com/cmp/allergan May 23rd, 2022 12:00AM Open Allergan Pharmaceutical & Biotechnology Allergan plc (NYSE: AGN), is a bold, global pharmaceutical company. Allergan is focused on developing, manufacturing and commercializing branded pharmaceuticals, devices and biologic products for patients around the world. Allergan markets a portfolio of leading brands and best-in-class products for the central nervous system, eye care, medical aesthetics and dermatology, gastroenterology, women’s health, urology and anti-infective therapeutic categories. Allergan is an industry leader in Open Science, the Company’s R&D model, which defines our approach to identifying and developing game-changing ideas and innovation for better patient care. This approach has led to Allergan building one of the broadest development pipelines in the pharmaceutical industry with 70+ mid-to-late stage pipeline programs in development. Our Company’s success is powered by our more than 16,000 global colleagues’ commitment to being Bold for Life. Together, we build bridges, power ideas, act fast and drive results for our customers and patients around the world by always doing what is right. With commercial operations in approximately 100 countries, Allergan is committed to working with physicians, healthcare providers and patients to deliver innovative and meaningful treatments that help people around the world live longer, healthier lives every day. For more information, visit Allergan’s website at www.Allergan.com. RRv1_1B_5B Brent Saunders 3.80 70.0 63.0 65.0 67.0 63.0 61.0 58.0 67.0 58.0 62.0 61.0 65.0 69.0 196.0 1326 1300 3.50 3.90 3.30 3.40 3.70 119.00 About a week 130.00 MEDIUM 133.00 FAVORABLE May 23rd, 2022 05:14AM May 23rd, 2022 05:14AM Health Care Pharmaceuticals & Biotechnology
nyse:abbv https://www.indeed.com/cmp/pharmacyclics,-an-abbvie-company May 22nd, 2022 12:00AM Open Pharmacyclics, an AbbVie Company Pharmaceutical & Biotechnology Pharmacyclics is an AbbVie company based in Silicon Valley, California and focused on developing and commercializing small-molecule medicines for the treatment of cancers and immune-mediated diseases for which there is great unmet medical need. We seek to discover innovative therapies to improve standards of care and strive to help our patients rediscover the Magic of Normal. Pharmacyclics is committed to the development and commercialization of novel therapies intended to improve the quality and duration of life and to resolve serious unmet medical needs for cancer patients. Pharmacyclics is a wholly-owned subsidiary of AbbVie (NYSE:ABBV), a global, research-based biopharmaceutical company. Oncology is a key therapeutic area for AbbVie, with a portfolio consisting of three marketed products and a pipeline containing multiple promising new molecules that are being studied in more than 200 clinical trials for over 20 different types of cancer. More than 1,200 Pharmacyclics and AbbVie research scientists, clinicians, marketing, operations, and corporate professionals work in the San Francisco Bay Area. They combine their expertise in immuno-oncology, stem cells, and cell-signaling with their knowledge of bispecific antibodies, antibody-drug conjugates (ADCs), and covalent-inhibitor technologies to discover and develop novel cancer treatments. Together, we are striving to outsmart cancer. RRv1_100M_500M 3.00 41.00 41.00 2.70 3.40 2.70 2.50 2.90 11.00 About two weeks 11.00 MEDIUM 11.00 FAVORABLE May 22nd, 2022 05:16AM May 22nd, 2022 05:16AM Health Care Pharmaceuticals & Biotechnology
nyse:abbv https://www.indeed.com/cmp/zeltiq-aesthetics May 22nd, 2022 12:00AM Open Zeltiq Aesthetics Zeltiq Aesthetics Inc. (NASDAQ: ZLTQ) is a global medical equipment supplier. The company's products include the CoolSculpting System which is used to do lipolysis, and Cryolipolysis as well as non-invasive technologies for plastic surgery. Cryolipolysis is an owned trademark of the company and it refers to equipment to destroy fat cells. The company has clearance from the U.S. Food and Drug Administration. RRv1_100M_500M 3.80 16.00 16.00 3.60 4.20 3.20 3.40 3.70 5.00 MEDIUM 5.00 FAVORABLE May 22nd, 2022 05:16AM May 22nd, 2022 05:16AM Health Care Pharmaceuticals & Biotechnology
nyse:abbv https://www.indeed.com/cmp/abbvie May 22nd, 2022 12:00AM Open AbbVie Pharmaceutical & Biotechnology AbbVie’s mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people’s lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women’s health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on Twitter, Facebook, Instagram, YouTube and LinkedIn. RRv1_OVER_10B Richard A. Gonzalez 3.90 73.0 68.0 73.0 69.0 66.0 64.0 64.0 71.0 62.0 66.0 64.0 70.0 72.0 398.0 1195 1200 3.70 4.00 3.40 3.40 3.70 260.00 About a week 292.00 MEDIUM 301.00 FAVORABLE May 22nd, 2022 05:16AM May 22nd, 2022 05:16AM Health Care Pharmaceuticals & Biotechnology
nyse:abbv https://www.indeed.com/cmp/allergan May 22nd, 2022 12:00AM Open Allergan Pharmaceutical & Biotechnology Allergan plc (NYSE: AGN), is a bold, global pharmaceutical company. Allergan is focused on developing, manufacturing and commercializing branded pharmaceuticals, devices and biologic products for patients around the world. Allergan markets a portfolio of leading brands and best-in-class products for the central nervous system, eye care, medical aesthetics and dermatology, gastroenterology, women’s health, urology and anti-infective therapeutic categories. Allergan is an industry leader in Open Science, the Company’s R&D model, which defines our approach to identifying and developing game-changing ideas and innovation for better patient care. This approach has led to Allergan building one of the broadest development pipelines in the pharmaceutical industry with 70+ mid-to-late stage pipeline programs in development. Our Company’s success is powered by our more than 16,000 global colleagues’ commitment to being Bold for Life. Together, we build bridges, power ideas, act fast and drive results for our customers and patients around the world by always doing what is right. With commercial operations in approximately 100 countries, Allergan is committed to working with physicians, healthcare providers and patients to deliver innovative and meaningful treatments that help people around the world live longer, healthier lives every day. For more information, visit Allergan’s website at www.Allergan.com. RRv1_1B_5B Brent Saunders 3.80 70.0 63.0 65.0 67.0 63.0 61.0 58.0 67.0 58.0 62.0 61.0 65.0 69.0 196.0 1326 1300 3.50 3.90 3.30 3.40 3.70 119.00 About a week 130.00 MEDIUM 133.00 FAVORABLE May 22nd, 2022 05:16AM May 22nd, 2022 05:16AM Health Care Pharmaceuticals & Biotechnology
nyse:abbv https://www.indeed.com/cmp/forest-pharmaceuticals May 22nd, 2022 12:00AM Open Forest Pharmaceuticals 3.80 138.00 138.00 3.40 3.70 3.10 3.30 3.50 May 22nd, 2022 05:16AM May 22nd, 2022 05:16AM Health Care Pharmaceuticals & Biotechnology

Request a demo to view additional historical data, and much more.

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.

Add widgets to your dashboards

Access existing maps, charts, word clouds, and other visualizations to understand your data quickly. Or build custom widgets to view data just the way you want it.